Mpox Vaccines Commitment: Bavarian Nordic to Deliver Two Million Doses for Africa

Thursday, 12 September 2024, 06:53

Mpox vaccines are set to increase in availability as Bavarian Nordic promises two million doses for Africa by the end of 2024. The manufacturer is also poised to supply an additional 13 million doses by 2025 to fulfill requests from Africa CDC and UNICEF. This initiative aims to enhance vaccination efforts across the continent.
LivaRava_Medicine_Default.png
Mpox Vaccines Commitment: Bavarian Nordic to Deliver Two Million Doses for Africa

Mpox Vaccines Commitment

Bavarian Nordic is making significant strides in the fight against mpox by pledging to deliver two million vaccines to Africa by the end of 2024. This boost in supply aims to address the urgent needs voiced by health authorities.

Further Supply Promises

  • Bavarian Nordic could also supply 13 million doses by the end of 2025.
  • This addition is in direct response to requests from the Africa CDC and UNICEF.
  • The company is committed to supporting vaccination campaigns across the continent.

Mpox remains a pertinent public health challenge, and increased vaccine availability is critical to controlling its spread.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe